SMTL ID : 6o1g.1

Full length human plasma kallikrein with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG.1: 1 residues within 4Å: Chain A: N.396 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.396, A:N.396 NAG.2: 2 residues within 4Å: Chain A: N.127, N.144 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.127, A:N.144

1 x 7SD: N-[(6-amino-2,4-dimethylpyridin-3-yl)methyl]-1-({4-[(1H-pyrazol-1-yl)methyl]phenyl}methyl)-1H-pyrazole-4-carboxamide(Non-covalent)

7SD.3: 19 residues within 4Å: Chain A: H.434, E.479, G.480, D.483, Y.555, K.556, M.561, D.572, A.573, C.574, K.575, S.578, T.596, S.597, W.598, G.599, E.600, G.601, C.602 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.555, A:K.575, A:T.596, A:W.598 Hydrogen bonds: A:A.573, A:S.597 Water bridges: A:G.480, A:E.600 pi-Stacking: A:H.434, A:W.598, A:W.598

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Partridge, J.R. et al., Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition. J.Struct.Biol. (2019)

Release Date

2019-03-06

Peptides

Plasma kallikrein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Plasma kallikrein